Health Technology Transfer

Strategic theme directors :

François Rousseau, M.D., M.Sc., FRCPC, Université Laval
Anne-Marie Laberge, M.D., Ph.D., Université de Montréal

Clinical diagnostic testing plays a critical role in 70% of clinical decisions related to admittance, diagnosis, therapy and discharge of patients. An accurate diagnosis can only be accomplished through the use of diagnostic tools that are thoroughly validated for many properties (analytical validity, clinical validity, clinical utility, cost-effectiveness and cost-utility) and supported by high-quality evidence. Furthermore, interpretation of genetic diagnostic tests requires comparison to highly annotated databases of reported mutations for each disease. A major objective of the RMGA is to encourage the translation of genetic discoveries into meaningful applications for the general public. The RMGA supports a number of Platforms that address this objective.

Genetic Testing Evidence-base Tracking Tool (GETT)GETT is a knowledge synthesis tool that systematizes the evidence base for introduction of a new molecular diagnostic tool in medicine.François Rousseau
Laboratoire de Simulation de DépistageA computed-based simulation facility that evaluates the cost-effectiveness of diagnostic algorithms for a genetic disease.François Rousseau